Cyberounds Logo
August 11, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Immunoglobulin G4-related Sclerosing Syndrome
CME credit is no longer available for this conference.
Peguy Saad, M.D., and Peter Barland, M.D.

Dr. Saad is Medical Resident at Staten Island University Hospital, New York, and Dr. Barland is Professor of Medicine (emeritus), Albert Einstein College of Medicine, Bronx, NY.

Within the past 12 months, Drs. Saad and Barland report no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.

Release Date: 05/17/2010
Termination Date: 05/17/2013

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the pathological reaction associated with IgG4 immunoglobulin production.
  • List the clinical features of IgG4-associated inflammation in various organs including the salivary and lacrimal glands, thyroid gland, the pancreas and the biliary ducts.
  • Manage the clinical features of the IgG4-associated inflammation in the aorta and retroperitoneal tissues.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity